Read the full article here.
This content was originally published by IoL Business Report. Original publishers retain all rights. It appears here for a limited time before automated archiving. By IoL Business Report
Swiss company Novartis says it will donate enough doses of malaria drug hydroxychloroquine to treat several million patients in the fight against the coronavirus if it wins approval.